Particulate delivery systems for vaccines

被引:67
作者
Bramwell, VW [1 ]
Perrie, Y [1 ]
机构
[1] Aston Univ, Sch Life & Hlth Sci, Med Res Unit, Birmingham B4 7ET, W Midlands, England
来源
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 2005年 / 22卷 / 02期
关键词
PLGA; liposome; DNA; niosome; adjuvant; ISCOM; vaccine; Mycobacterium tuberculosis; HIV;
D O I
10.1615/CritRevTherDrugCarrierSyst.v22.i2.20
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review focuses on the use of particulate delivery systems for the purposes of immunization. This includes poly(lactide-co-glycolide) (PLGA), ISCOMs, liposomes, niosomes, virosomes, chitosan, and other biodegradable polymers. These systems are evaluated in terms of their use as carriers for protein subunit and DNA vaccines. There is an extensive focus on recent literature, the understanding of biological interactions, and relation of this to our present understanding of immunological mechanisms of action. In addition, there is consideration of formulation techniques including emulsification, solvent diffusion, DNA complexation, and entrapment. The diversity of formulation strategies presented is a testament to the exponential growth and interest in the area of vaccine delivery systems. A case study for the application of particulate vaccine carriers is assessed in terms of vaccine development and recent insights into the possible design and application of vaccines against two of the most important pathogens that threaten mankind and for which there is a significant need: Mycobacterium tuberculosis and human immunodeficiency virus. This review addresses the rationale for the use of particulate delivery systems in vaccine design in the context of the diversity of carriers for DNA- and protein-based vaccines and their potential for application in terms of the critical need for effective vaccines.
引用
收藏
页码:151 / 214
页数:64
相关论文
共 310 条
[1]   Tuberculosis in HIV-infected patients:: a comprehensive review [J].
Aaron, L ;
Saadoun, D ;
Calatroni, I ;
Launay, O ;
Mémain, N ;
Vincent, V ;
Marchal, G ;
Dupont, B ;
Bouchaud, O ;
Valeyre, D ;
Lortholary, O .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (05) :388-398
[2]   Ceramide inhibits IL-2 production by preventing protein kinase C-dependent NF-κB activation:: Possible role in protein kinase Cθ regulation [J].
Abboushi, N ;
El-Hed, A ;
El-Assaad, W ;
Kozhaya, L ;
El-Sabban, ME ;
Bazarbachi, A ;
Badreddine, R ;
Bielawska, A ;
Usta, J ;
Dbaibo, GS .
JOURNAL OF IMMUNOLOGY, 2004, 173 (05) :3193-3200
[3]   A novel TB vaccine; towards a strategy based on our understanding of BCG failure [J].
Agger, EM ;
Andersen, P .
VACCINE, 2002, 21 (1-2) :7-14
[4]   Mammalian cell-entry proteins encoded by the mce3 operon of Mycobacterium tuberculosis are expressed during natural infection in humans [J].
Ahmad, S ;
El-Shazly, S ;
Mustafa, AS ;
Al-Attiyah, R .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (04) :382-391
[5]  
Akbar Sk. Md. Fazle, 2004, Current Drug Targets - Infectious Disorders, V4, P93, DOI 10.2174/1568005043340885
[6]   Mammalian Toll-like receptors [J].
Akira, S .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (01) :5-11
[7]   In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis [J].
Al-Attiyah, R ;
Mustafa, AS ;
Abal, AT ;
El-Shamy, ASM ;
Dalemans, W ;
Skeiky, YAW .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (01) :139-144
[8]   LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS [J].
ALLISON, AC ;
GREGORIADIS, G .
NATURE, 1974, 252 (5480) :252-252
[9]   Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery [J].
Alpar, HO ;
Somavarapu, S ;
Atuah, KN ;
Bramwell, V .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (03) :411-430
[10]   Current status of DNA vaccines and their route of administration [J].
Alpar, HO ;
Bramwell, VW .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2002, 19 (4-5) :307-383